Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.77
-0.30-3.72%
Last update: Oct 12, 4:53 PM
$7.90
-0.17-2.11%
Regenxbio Inc (RGNX) Stock Price, Quote, News & History
RGNXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins....
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.
Other companies in Regenxbio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Regenxbio has a consensus price target of $23.67.
The stock price for Regenxbio (NASDAQ: RGNX) is $7.9 last updated October 12, 2026 at 4:53 PM EDT.
There are no upcoming dividends for Regenxbio.
Regenxbio does not have any upcoming earnings scheduled.
There is no upcoming split for Regenxbio.
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
